Mark vB Cleveland,John S. Fordtran,Edmund V. Dennett
申请号：
US15456497
公开号：
US20170182090A1
申请日:
2017.03.11
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention is generally directed to an oral pharmaceutical composition comprising a sulfate salt, for example, sodium sulfate and/or potassium sulfate, wherein the composition is substantially free of magnesium sulfate. The present invention is further directed to use of such oral pharmaceutical compositions to induce laxation or to treat or prevent constipation, e.g., opioid-induced constipation.
